IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.578
AS - Asia 952
NA - Nord America 918
SA - Sud America 134
AF - Africa 14
AN - Antartide 1
Totale 3.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 878
RU - Federazione Russa 781
CN - Cina 348
SG - Singapore 347
RO - Romania 264
IT - Italia 159
SE - Svezia 115
BR - Brasile 112
HK - Hong Kong 88
DE - Germania 78
VN - Vietnam 70
FR - Francia 54
GB - Regno Unito 41
CA - Canada 28
FI - Finlandia 26
IN - India 24
NL - Olanda 15
BD - Bangladesh 13
PL - Polonia 12
JP - Giappone 11
AR - Argentina 10
MX - Messico 10
IQ - Iraq 9
AT - Austria 8
PH - Filippine 7
ZA - Sudafrica 7
ID - Indonesia 6
IE - Irlanda 6
TR - Turchia 6
EG - Egitto 5
LT - Lituania 5
CO - Colombia 4
ES - Italia 4
UA - Ucraina 4
PK - Pakistan 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
IR - Iran 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.597
Salva come PNG Salva come JPEG
Città #
Dallas 217
Singapore 185
Moscow 154
Ashburn 121
San Jose 94
Hong Kong 86
Shanghai 73
Beijing 62
Munich 47
Milan 43
Hefei 36
New York 34
Lauterbourg 32
Ho Chi Minh City 31
Los Angeles 30
Lawrence 20
Princeton 20
Boardman 19
Orem 19
Helsinki 17
Rome 16
Montreal 13
São Paulo 13
Atlanta 12
Warsaw 11
Toronto 10
Amsterdam 9
Hanoi 9
Houston 9
Nuremberg 9
Santa Clara 8
Brooklyn 7
Cesano Boscone 7
Chennai 7
Chicago 7
Guangzhou 7
London 7
Manchester 7
Tokyo 7
Frankfurt am Main 6
Johannesburg 6
Turku 6
Denver 5
New Delhi 5
Shenzhen 5
Stockholm 5
Ancona 4
Ankara 4
Boston 4
Pune 4
Quezon City 4
Seattle 4
The Dalles 4
Baghdad 3
Baie-D'Urfé 3
Ballincollig 3
Barnet 3
Bexley 3
Cairo 3
City of London 3
Council Bluffs 3
Da Nang 3
Dublin 3
Falkenstein 3
Genoa 3
Jundiaí 3
Mumbai 3
Osimo 3
Paris 3
Poli 3
Poplar 3
Rio de Janeiro 3
Salvador 3
San Antonio 3
San Giuliano 3
Vittoria 3
York 3
Aobadai 2
Assago 2
Bauru 2
Belo Horizonte 2
Bologna 2
Bosco Chiesanuova 2
Brescia 2
Buffalo 2
Campinas 2
Castel Mella 2
Concórdia 2
Dalmine 2
Dhaka 2
Diadema 2
Fermo 2
Florence 2
Ghent 2
Hangzhou 2
Honcho 2
Indianapolis 2
Jakarta 2
Joinville 2
Kansas City 2
Totale 1.699
Salva come PNG Salva come JPEG
Nome #
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 372
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 185
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
Biobanking for COVID-19 research 144
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 120
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 119
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 113
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 112
COVID-19: Pharmacology and kinetics of viral clearance 103
Drug retention rates of biological agents in adult onset Still's disease 101
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 98
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 94
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 94
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 94
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 93
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 93
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 93
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 91
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 90
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 90
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 89
Obesity and its role in the management of rheumatoid and psoriatic arthritis 87
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 83
Current treatment options and safety considerations when treating adult-onset Still’s disease 83
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 80
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 77
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 69
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 68
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 68
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 63
Low prevalence of arrhythmias in clinically stable COVID-19 patients 61
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 58
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 58
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 57
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 56
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 51
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort 45
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 45
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease 39
Totale 3.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 2 1
2021/202248 1 0 12 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025909 56 15 21 28 42 50 358 66 92 36 47 98
2025/20262.243 169 167 183 286 181 66 203 197 687 104 0 0
Totale 3.687